Results 61 to 70 of about 99,913 (245)

Leptin May Promote Eosinophilic CRSwNP Progression by Enhancing Eosinophil Chemotaxis and Angiogenesis Under a Type 2 Inflammatory Milieu

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyp (CRSwNP) is a heterogeneous Type 2 inflammatory disease characterized by enhanced eosinophilic infiltration. Both innate and adaptive immunity are involved in the onset and progression of CRSwNP.
Yuki Sonoda   +4 more
wiley   +1 more source

Changes of serum adiponectin and soluble intercellular adhesion molecule-1 concentrations after smoking cessation

open access: yes, 2014
[[abstract]]Background: This study aims to investigate the effect of increased serum adiponectin concentration during smoking cessation on soluble intercellular adhesion molecule-1 (sICAM-1) concentration.
Tsai, Jaw-Shiun;Guo, Fei-Ran;Chen, Su-Chiu;Lue, Bee-Horng;Lee, Long-Teng;Huang, Kuo-Chin;Chen, Chin-Ying;Hung, Shou-Hung;Chuang, Lee-Ming;Chen, Ching-Yu   +2 more
core   +1 more source

willov/adiponectin-epi: Intital release

open access: yes, 2020
This is the version used when submitting the manuscript titled "A systems biology analysis of adrenergically stimulated adiponectin exocytosis in white ...
willov
core   +1 more source

The 9+ month marathon: How pregnancy may have shaped human endurance capacities

open access: yesThe Anatomical Record, EarlyView.
Abstract Anthropology has long considered the evolution of our uniquely human endurance capacities to be the result of selection upon anatomical and physiological features imposed by the demands of thermoregulation and resource acquisition, particularly during the demands of persistence hunting. Research has focused on the anatomical changes present in
Cara Ocobock
wiley   +1 more source

Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio

open access: yesJournal of Obesity, 2013
Background. High adiponectin/leptin ratio may be protective from metabolic risks imparted by high triglyceride, low HDL, and insulin resistance. Methods.
Gloria Lena Vega, Scott M. Grundy
doaj   +1 more source

Hypothalamic POMC deficiency increases circulating adiponectin despite obesity

open access: yesMolecular Metabolism, 2020
Objective: The steep rise in the prevalence of obesity and its related metabolic syndrome have become a major worldwide health concerns. Melanocortin peptides from hypothalamic arcuate nucleus (Arc) POMC neurons induce satiety to limit food intake ...
Hui Yu   +6 more
doaj   +1 more source

Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

open access: yesArthritis &Rheumatology, EarlyView.
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu   +2 more
wiley   +1 more source

Association of Adiponectin and Metabolic Syndrome among Patients Taking Atypical Antipsychotics for Schizophrenia: A Cohort Study

open access: yes, 2010
introduction: Adiponectin, an adipocyte-derived hormone controlling lipid and carbohydrate metabolism, has been suggested to be a biomarker for metabolic syndrome in the general population.
白雅美;陳姿婷;楊偉勛;林朝誠;劉英杰;王瑛杰;蘇東平;周碧瑟;陳震宇   +1 more
core   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Home - About - Disclaimer - Privacy